|
1
|
Takahashi K and Yamanaka S: Induction of
pluripotent stem cells from mouse embryonic and adult fibroblast
cultures by defined factors. Cell. 126:663–676. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Takahashi K, Tanabe K, Ohnuki M, Narita M,
Ichisaka T, Tomoda K and Yamanaka S: Induction of pluripotent stem
cells from adult human fibroblasts by defined factors. Cell.
131:861–872. 2007. View Article : Google Scholar
|
|
3
|
Yamanaka S: Elite and stochastic models
for induced pluripotent stem cell generation. Nature. 460:49–52.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ben-Porath I, Thomson MW, Carey VJ, Ge R,
Bell GW, Regev A and Weinberg RA: An embryonic stem cell-like gene
expression signature in poorly differentiated aggressive human
tumors. Nat Genet. 40:499–507. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lengerke C, Fehm T, Kurth R, Neubauer H,
Scheble V, Müller F, Schneider F, Petersen K, Wallwiener D, Kanz L,
Fend F, Perner S, Bareiss PM and Staebler A: Expression of the
embryonic stem cell marker SOX2 in early-stage breast carcinoma.
BMC Cancer. 11:422011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ponti D, Costa A, Zaffaroni N, Pratesi G,
Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tetreault MP, Wang ML, Yang Y, Travis J,
Yu QC, Klein-Szanto AJ and Katz JP: Klf4 overexpression activates
epithelial cytokines and inflammation-mediated esophageal squamous
cell cancer in mice. Gastroenterology. 139:2124–2134. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H
and Liu Z: MicroRNA-10b promotes migration and invasion through
KLF4 in human esophageal cancer cell lines. J Biol Chem.
285:7986–7994. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jeter CR, Badeaux M, Choy G, Chandra D,
Patrawala L, Liu C, Calhoun-Davis T, Zaehres H, Daley GQ and Tang
DG: Functional evidence that the self-renewal gene NANOG regulates
human tumor development. Stem Cells. 27:993–1005. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Glinsky GV: ‘Stemness’ genomics law
governs clinical behavior of human cancer: implications for
decision making in disease management. J Clin Oncol. 26:2846–2853.
2008.
|
|
11
|
Chiou SH, Wang ML, Chou YT, Chen CJ, Hong
CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS and Wu CW:
Coexpression of Oct4 and Nanog enhances malignancy in lung
adenocarcinoma by inducing cancer stem cell-like properties and
epithelial-mesenchymal transdifferentiation. Cancer Res.
70:10433–10444. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hickman ES, Moroni MC and Helin K: The
role of p53 and pRB in apoptosis and cancer. Curr Opin Genet Dev.
12:60–66. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pan G and Thomson JA: Nanog and
transcriptional networks in embryonic stem cell pluripotency. Cell
Res. 17:42–49. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin T, Chao C, Saito S, Mazur SJ, Murphy
ME, Appella E and Xu Y: p53 induces differentiation of mouse
embryonic stem cells by suppressing Nanog expression. Nat Cell
Biol. 7:165–171. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bartkova J, Horejsi Z, Koed K, Kramer A,
Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C,
Orntoft T, Lukas J and Bartek J: DNA damage response as a candidate
anti-cancer barrier in early human tumorigenesis. Nature.
434:864–870. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gorgoulis VG, Vassiliou LV, Karakaidos P,
Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA Jr,
Kastrinakis NG, Levy B, Kletsas D, Yoneta A, Herlyn M, Kittas C and
Halazonetis TD: Activation of the DNA damage checkpoint and genomic
instability in human precancerous lesions. Nature. 434:907–913.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rich AM, Kerdpon D and Reade PC: p53
expression in oral precancer and cancer. Aust Dent J. 44:103–105.
1999. View Article : Google Scholar
|
|
18
|
Pontén J: Cell biology of precancer. Eur J
Cancer. 37:S97–S113. 2001.
|
|
19
|
Ozols R: Esophageal cancer. Curr Problems
Cancer. 18:191–246. 1994.
|
|
20
|
Fong LYY, Ishii H, Nguyen VT, Vecchione A,
Farber JT, Croce CM and Huebner K: p53 deficiency accelerates
induction and progression of esophageal and forestomach tumors in
zinc-deficient mice. Cancer Res. 63:186–195. 2003.PubMed/NCBI
|
|
21
|
Carlton PS, Kresty LA, Siglin JC, Morse
MA, Lu J, Morgan C and Stoner GD: Inhibition of
N-nitrosomethylbenzylamine-induced tumorigenesis in the rat
esophagus by dietary freeze-dried strawberries. Carcinogenesis.
22:441–446. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dumon KR, Ishii H, Fong LYY, Zanesi N,
Fidanza V, Mancini R, Vecchione A, Baffa R, Trapasso F, During MJ,
Huebner K and Croce CM: FHIT gene therapy prevents tumor
development in Fhit-deficient mice. Proc Natl Acad Sci USA.
98:3346–3351. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Coia LR: The esophagus. Moss’ Radiation
Oncology: Rationale, Techniques, Results. Cox J: Mosby-Year Book;
St. Louis: pp. 4091994
|
|
24
|
Blot WJ: Esophageal cancer trends and risk
factors. Semin Oncol. 21:403–410. 1994.PubMed/NCBI
|
